Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss.
Kwak HB, Kim JY, Kim KJ, Choi MK, Kim JJ, Kim KM, Shin YI, Lee MS, Kim HS, Kim JW, Chun CH, Cho HJ, Hong GY, Juhng SK, Yoon KH, Park BH, Bae JM, Han JK, Oh J.
Kwak HB, et al. Among authors: park bh.
Biol Pharm Bull. 2009 Jul;32(7):1193-8. doi: 10.1248/bpb.32.1193.
Biol Pharm Bull. 2009.
PMID: 19571384
Free article.